COMMUNIQUÉS West-GlobeNewswire

SK pharmteco annonce un investissement de plus de 200 millions de dollars aux États-Unis pour renforcer ses capacités de production de petites molécules et de peptides
30/09/2026
RANCHO CORDOVA, Californie, 30 sept. 2026 (GLOBE NEWSWIRE) -- SK pharmteco a annoncé aujourd’hui un plan d’investissement global de plus de 200 millions de dollars sur cinq ans destiné à étendre et à moderniser ses [...]
Two Lipidomics Excellence Awards Led to Two Major Publications
30/09/2026
Two recipients of Lipotype's Lipidomics Excellence Award have published award-supported lipid research at major scientific publications DRESDEN, Germany, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Lipotype introduced the [...]
Celularity Highlights Anticipated Quarter One 2027 Opening of Fontaine Vitale as Strategic Partner
30/09/2026
Fontaine Vitale represents a significant new market and revenue opportunity for Celularity in the Asia-Pacific region FLORHAM PARK, N.J., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” [...]
Legend Senior Living Associate Stephanie Vacanti Honored as 2026 TALA Hero Award Recipient
30/09/2026
MANSFIELD, Texas, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Stephanie Vacanti, Health Care Director at Legend of Mansfield, has been recognized by the Texas Assisted Living Association (TALA) as a 2026 TALA Hero Award [...]
Applied Biologics Publishes New Translational Research Demonstrating Ligament Regeneration with XWRAP®-Based Biologic Augmentation
30/09/2026
Preclinical orthopedic study demonstrates progressive restoration of native-like collagen architecture, supporting continued investigation of XWRAP in surgical and sports medicine applications SCOTTSDALE, Ariz., Sept. [...]
Excellent Brain Partners with Scholas Occurrentes to Bring ADHD Neurofeedback Training to Schools and Universities Worldwide
30/09/2026
Collaboration agreement extends Excellent Brain's neurofeedback attention-training platform to Scholas's global network of 500,000 schools and universities across 70 countries, reaching an estimated 2.5 million young [...]
Solana Company (NASDAQ: HSDT) Announces Pricing of $15 Million Registered Direct Offering with a Global Institutional Investor
30/09/2026
PHILADELPHIA, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed digital asset treasury, infrastructure, and services company providing institutional access to [...]
NewGen Announces Closing of $1.25 Million Public Offering
30/09/2026
BANGKOK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative [...]
Decoy Therapeutics to Present at The Small Cap Showcase
30/09/2026
CEO Rick Pierce to deliver an investor presentation on Thursday, October 1 in New York CAMBRIDGE, Mass., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Decoy Therapeutics, Inc . (NASDAQ: DCOY), a biotechnology company pioneering [...]
Project MEND Uses SteraMist to Safely Disinfect Medical Equipment for Reuse
30/09/2026
FREDERICK, Md., Sept. 30, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today announced Project MEND , a San [...]
Candel Therapeutics Announces Integrated Clinical and Biomarker Data That Showed Durable Local and Systemic Immune Activation after Aglatimagene Besadenovec in Intermediate-Risk Localized Prostate Cancer
30/09/2026
Novel systemic immune data demonstrated T-cell activation following local administration of aglatimagene. Together with recently disclosed evidence of persistent local immune remodeling, these findings provide [...]
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
30/09/2026
FDA pre-submission feedback supports a Class II strategy, leveraging substantial equivalence to a previously cleared device, positioning the Company for potential initial U.S. clearance of its standalone sensing [...]
Novo’s investigational obesity and diabetes drug CagriSema reduces ‘food noise’ and shows benefits in organ and bone health – EASD 2026
30/09/2026
In a year-long functional magnetic resonance imaging (fMRI) study - a non-invasive method to measure brain activity during specific tasks - CagriSema changed how the brain reacted to tempting, high-calorie foods in [...]
Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND
30/09/2026
Repeat-dose GLP toxicology study showed no ERNA-101-related adverse findings across all dose levels tested, including no clinical pathology or histopathology findings; single-dose assessment showed no evidence of acute [...]
AIM ImmunoTech Discusses Ampligen®’s Potential to Complement Emerging Pancreatic Cancer Therapies in New CEO Corner Video
30/09/2026
Company highlights supportive survival observations, potential for biomarker-driven patient selection and upcoming Phase 2 DURIPANC milestones Access it here OCALA, Fla., Sept. 30, 2026 (GLOBE NEWSWIRE) -- AIM [...]
Avaí Bio and Austrianova Successfully Encapsulate GMP-Quality Klotho-Producing Cells, Achieve Robust Klotho Secretion
30/09/2026
LAS VEGAS, NEVADA, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotech developing transformative cell-based therapies for diabetes, age-related disorders, and [...]
Silo Pharma’s QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime Flexibility
30/09/2026
Addition of NVIDIA Nemotron models and Hermes runtime expands customer choice across both AI models and agent software SARASOTA, FLA., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO) (“Silo” or “the [...]
OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution
30/09/2026
First party, direct-from-source Real World Data will feed the Company’s tenth channel partner’s AI models and a licensable derivative dataset that partner will sell MINNEAPOLIS, Sept. 30, 2026 (GLOBE NEWSWIRE) -- [...]
Highlight Therapeutics Presents Positive Phase 2b Topline Results of Intralesional BO-112 in Localized Basal Cell Carcinoma as a Late-Breaker at EADV
30/09/2026
Primary composite endpoint met: 61% of patients achieved visual and pathological response across all treated lesions. Complete clinical and pathological response in 56% of high-risk head & neck patients and 62% of [...]

Pages